Core Insights - Bio-Techne Corporation has launched Cultrex™ Synthetic Hydrogel, a synthetic extracellular matrix designed to enhance 3D stem cell and organoid research by reducing lot-to-lot variability and supporting reproducible workflows [1][3] Product Overview - Cultrex Synthetic Hydrogel supports 3D organoid models for applications such as drug screening, toxicology, and personalized medicine, minimizing reliance on animal-derived matrices and facilitating the use of new approach methodologies (NAMs) [2] - The hydrogel's controlled composition ensures consistency and traceability, aligning with regulatory requirements and enhancing preclinical research outcomes [3] Market Positioning - The launch of Cultrex Synthetic Hydrogel reflects the evolving needs of researchers transitioning from discovery to translational workflows, providing a scalable and reproducible option without compromising performance [4] - Bio-Techne's portfolio now includes a range of solutions for stem cell and organoid culture, offering flexibility to meet various experimental and regulatory needs [4] Company Background - Bio-Techne Corporation generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people globally, providing innovative tools and reagents for research and clinical diagnostics [6]